Sacituzumab govitecan: ascending the treatment algorithm in triple negative breast cancer.

ABSTRACT:

SUBMITTER: Rozenblit M 

PROVIDER: S-EPMC9073796 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature